LYRA Stock Summary and Trading Ideas (Lyra Therapeutics | NASDAQ:LYRA)

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Lyra Therapeutics trades on the NASDAQ stock market under the symbol LYRA.

As of January 23, 2026, LYRA stock price declined to $2.05 with 88,496 million shares trading.

LYRA has a beta of 2.85, meaning it tends to be more sensitive to market movements. LYRA has a correlation of 0.06 to the broad based SPY ETF.

LYRA has a market cap of $3.64 million. This is considered a Sub-Micro Cap stock.

Last quarter Lyra Therapeutics reported $25,000 in Revenue and -$3.38 earnings per share. This fell short of revenue expectation by $-111,550 and exceeded earnings estimates by $1.45.

In the last 3 years, LYRA traded as high as $339.50 and as low as $1.63.

The top ETF exchange traded funds that LYRA belongs to (by Net Assets): VXF.

LYRA has underperformed the market in the last year with a price return of -78.7% while the SPY ETF gained +14.9%. LYRA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -68.4% and -46.1%, respectively, while the SPY returned +3.5% and 0.0%, respectively.

LYRA support price is $2.03 and resistance is $2.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LYRA shares will trade within this expected range on the day.